Andreessen Horowitz January 28, 2025
Alexander Saint-Amand, Julie Yoo, Olivia Webb, and Kris Tatiossian

Alexander Saint-Amand, cofounder and CEO of Topography, reflects on his journey from leading Gerson Lehrman Group (GLG), a pioneer in expert networks, to tackling systemic barriers in clinical trials at his current company, Topography. Inspired by personal experiences, Alexander’s mission centers on democratizing access to clinical research by transforming community-based practices into thriving hubs for trials. Alongside a16z Bio + Health general partner Julie Yoo, he...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Conferences / Podcast, Trends
The New Product Development Landscape: Navigating the Challenges
Lindus Health completes $55m funding round
Bridging Clinical Research Gaps: How Site Augmentation Enhances Trial Success
Key Lead Generation Providers and Technology Solutions for the Clinical Trials Industry
Google DeepMind CEO: AI-Designed Drugs Coming to Clinical Trials in 2025

Share This Article